Medication Reconciliation and Drug–Drug Interactions: An Old Process with a New Approach
Abstract
Background: The occurrence of drug–drug interactions (DDIs) and insufficient attention to medication reconciliation is one of the important challenges of pharmacotherapy in hospitalized patients. The aim of this study was to determine the extent of drug–drug interactions in patients based on medication reconciliation strategy. Methods: This descriptive cross-sectional study was performed for six months in patients admitted
to Imam Reza Hospital in Amol, North of Iran. The data were obtained by using a medication reconciliation tool through a random sampling of patients admitted in Hospital wards from May 2014 until October 2014. A total of 200 patients were enrolled in the study. All patients had a history of medication use before admission. The drug interactions have been checked according to Drug Interaction Facts between newly prescribed drug and medication patient using before admission. The number and frequency of data were summarized by SPSS21 statistical software. Results: Major and Moderate DDIs were found in 7.5% and 64% of prescriptions. The most frequent DDIs were seen in those who were taking psychiatric drugs (33%) and cardiovascular drugs (30%). Most DDIs occurred among women over 60 years of age. The most frequently occurring DDIs was pharmacokinetics interaction between clopidogrel and atorvastatin (n=9). Other frequent interactions were between ceftriaxone and heparin (n=8) and metoprolol and insulin (n=3). Conclusion: This study showed a high rate of drug interactions and especially confirms the importance of medication reconciliation in providing a comprehensive drug history and exploring drug interactions.
2. Marinović I, Vrca VB, Samardžić I, Marušić S, Grgurević I. Potentially inappropriate medications involved in drug–drug interactions at hospital discharge in Croatia. Int J Clin Pharm. 2020. doi: 10.1007/s11096-020- 01164-4. In press.
3. Patel NS, Patel TK, Patel PB, Naik VN, Tripathi CB. Hospitalizations due to preventable adverse reactions—a systematic review. Eur J Clin Pharmacol 2017;73(4):385-98.
4. Morimoto T, Gandhi TK, Seger AC, Hsieh TC, Bates DW. Adverse drug events and medication errors: detection and classification methods. BMJ Qual Saf 2004 ;13(4):306-14.
5. McEvoy DS, Sittig DF, Hickman TT, et al. Variation in high-priority drug-drug interaction alerts across institutions and electronic health records. J Am Med Inform Assoc 2017;24(2):331-8.
6. Classen DC, Pestotnik SL, Evans RS, Burke JP. Computerized surveillance of adverse drug events in hospital patients. JAMA 1991;266(20):2847-51.
7. Aronson J. Medication reconciliation. BMJ. 2017;356:i5336.
8. Aghajani MH, Ghazaeian M, Mehrazin HR, Sistanizad M, Miri M. Errors related to medication reconciliation: A prospective study in patients admitted to the post CCU. Iran J PharmSci.. 2016;15(2):599-604.
9. Berthe A, Fronteau C, Le Fur É, et al. Medication reconciliation: a tool to prevent adverse drug events in geriatrics medicine. Geriatr Psychol Neuropsychiatr Vieil 2017;15(1):19-24.
10. Makiani MJ, Nasiripour S, Hosseini M, Mahbubi A. Drug-drug interactions: The importance of medication reconciliation. J Res Pharm Pract 2017;6(1):61-62.
11. Reiner B, inventor. Medical reconciliation, communication, and educational reporting tools. United States patent application US 13/403,529. 2012.
12. Tatro DS. Drug Interaction Facts 2013: The Authority on Drug Interactions. Missouri: Wolters Kluwer Health; 2012.
13.Busa G, Burlina A, Damuzzo V, Chiumente M, Palozzo AC. Comorbidity, polytherapy, and drug interactions in a neurological context: an example of a multidisciplinary approach to promote the rational use of drugs. J Pharm
Pract 2018;31(1):58-65.
14. Karimzadeh I, Mirjalili M, Mirzaei E, Mottaghi S, Vazin A. Medication reconciliation at admission by pharmacists in a teaching referral hospital in Iran. Trends in Pharmaceutical Sciences 2019;5(1):65-72.
15. Zarif-Yeganeh M, Rastegarpanah M, Garmaroudi G, Hadjibabaie M, Vahedi HSM. Incidence of medication discrepancies and its predicting factors in emergency department.Iran J Public Health 2017;46(8):1086-94.
16. Atella V, Piano Mortari A, Kopinska J, et al. Trends in age-related disease burden and healthcare utilization. Aging Cell 2019;18(1):e12861.
17. Juurlink DN, Mamdani M, Kopp A, Laupacis A, Redelmeier DA. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 2003;289(13):1652-8.44 jpc.tums.ac.ir March 2021;9(1) Medication Reconciliation and Drug–Drug Interactions
18. Ahmad A, Khan MU, Haque I, et al. Evaluation of potential drug-drug interactions in general medicine ward of teaching hospital in southern India. J Clin Diagn Res 2015;9(2):FC10-3.
19. Alomar MJ. Factors affecting the development of adverse drug reactions. Saudi Pharm J. 2014;22(2):83-94.
20.Gallagher P, Ryan C, Byrne S, Kennedy J, O Mahony D. STOPP (screening tool of older person’s prescriptions) and START (screening tool to alert doctors to right treatment). Consensus validation. Int J Clin Pharmacol Ther
2008;46(2):72.
21. World Health Organization. ICD-10 : international statistical classification of diseases and related health problems: tenth revision. 2nd ed. Geneva: World Health Organization; 2004.
| Files | ||
| Issue | Vol 9, No 1 (Winter 2021) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/jpc.v9i1.6035 | |
| Keywords | ||
| Drug Interactions; Medication Reconciliation; Drug Therapy; Patient Safety | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
